Exploration of the Cellular and Molecular Mechanisms in Patients Receiving Biotherapies Targeting the IL-23/IL-17 Axis in Cutaneous Psoriasis

RecruitingOBSERVATIONAL
Enrollment

90

Participants

Timeline

Start Date

December 14, 2021

Primary Completion Date

June 30, 2028

Study Completion Date

June 30, 2028

Conditions
Psoriasis
Interventions
OTHER

Blood sample

Blood will be collected in tubes heparinés BD (Vacutainer), homogenised, and immediately transported at room temperature to Institut Pasteur to be further processed

OTHER

Data collection

collection of socio-demographic, clinical and biological data.

OTHER

skin biopsies

skin biopsies of 4 mm in diameter. These samples will not be taken on the face or in an area of skin folds

Trial Locations (1)

75015

RECRUITING

Lars ROGGE, Paris

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Janssen Biotech, Inc.

INDUSTRY

lead

Institut Pasteur

INDUSTRY